Visión generalGráficoNoticiasTraderScreen

IWG PLC/  JE00BYVQYS01  /

Nasdaq Other OTC
06/11/2024  21:23:11 Diferencia +0.0767 Volumen Bid- Ask- Máximo del día Price Change Band
2.2500USD +3.53% 71,900
Volumen de negocios: 160,068.4500		 -Volumen de oferta: - -Tamaño/ Volumen/ Formato de Ask: - 2.2500 2.2000
GlobeNewswire 26/03 argenx Announces Approval of VYVGART (efgartigimod alfa) in Japan for Adults with Primary Immune Thr...
GlobeNewswire 11/12/2023 Keros Therapeutics Presents Clinical Data from its KER-050 Program at the 65th American Society of H...
GlobeNewswire 28/11/2023 argenx Reports Topline Results from ADVANCE-SC Study of VYVGART Hytrulo in Primary Immune Thrombocyt...
Newsfile Corp 05/10/2023 GoGlobal Announces Partnership with IWG to Offer Office Space and Hybrid Working Solutions to Client...
GlobeNewswire 24/02/2022 Teleflex Announces Fourth Quarter and Full-Year 2021 Financial Results
GlobeNewswire 13/12/2021 Corrected: Keros Therapeutics Presents Clinical Trial and Preclinical Study Results from its KER-050...
GlobeNewswire 13/12/2021 Keros Therapeutics Presents Clinical Trial and Preclinical Study Results from its KER-050 Program an...
GlobeNewswire 12/11/2021 Biosight Announces Initiation of Phase 2 Clinical Trial of Aspacytarabine for MDS and AML
GlobeNewswire 09/08/2021 HUTCHMED and Epizyme Announce Strategic Collaboration to Develop and Commercialize TAZVERIK® (tazeme...
GlobeNewswire 29/07/2021 Teleflex Reports Second Quarter 2021 Results and Full Year Outlook
GlobeNewswire 13/05/2021 Carbon180 Unveils Carbon Removal Policy Roadmap for 2021 and Beyond
GlobeNewswire 29/04/2021 Teleflex Reports First Quarter 2021 Results
GlobeNewswire 25/02/2021 Teleflex Reports Fourth Quarter and Full Year 2020 Results; Provides 2021 Guidance
GlobeNewswire 28/12/2020 Aprea Therapeutics Announces Results of Primary Endpoint from Phase 3 Trial of Eprenetapopt in TP53 ...
GlobeNewswire 06/12/2020 MacroGenics Presents Flotetuzumab Data in Patients with Refractory Acute Myeloid Leukemia at the 202...
GlobeNewswire 29/10/2020 Teleflex Reports Third Quarter 2020 Results
GlobeNewswire 30/07/2020 Teleflex Reports Second Quarter 2020 Results
GlobeNewswire 12/06/2020 Aprea Therapeutics Presents Results From French Phase Ib/II Clinical Trial of APR-246 (Eprenetapopt)...
GlobeNewswire 30/04/2020 Teleflex Reports First Quarter 2020 Results
GlobeNewswire 27/04/2020 MacroGenics Announces Presentation of Flotetuzumab Translational Data at the 2020 AACR Annual Meetin...
GlobeNewswire 20/02/2020 Teleflex Reports Fourth Quarter and Full Year 2019 Results; Provides 2020 Guidance
GlobeNewswire 12/12/2019 Recap and Update of Positive Data from Phase Ib/II Clinical Trials of APR-246 and Azacitidine (AZA) ...
GlobeNewswire 10/12/2019 Stemline Therapeutics Recaps ELZONRIS Clinical Data Presentations in Patients with Myelofibrosis (or...
GlobeNewswire 09/12/2019 MacroGenics Presents Flotetuzumab Data in Patients with Primary Induction Failure and Early Relapsed...
GlobeNewswire 09/12/2019 Aprea Therapeutics Presents Results From U.S. Phase Ib/II Clinical Trial of APR-246 and Azacitidine ...